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The IkB kinase complex (IKK) is a key regulator of
immune responses, inflammation, cell survival, and
tumorigenesis.Theprosurvival functionof IKKcenters
on activation of the transcription factor NF-kB, whose
target gene products inhibit caspases and prevent
prolonged JNK activation. Here, we report that inacti-
vation of the BH3-only protein BAD by IKK indepen-
dently of NF-kB activation suppresses TNFa-induced
apoptosis. TNFa-treated Ikkb/ mouse embryonic
fibroblasts (MEFs) undergo apoptosis significantly
faster than MEFs deficient in both RelA and cRel due
to lackof inhibitionofBADby IKK. IKKphosphorylates
BADat serine-26 (Ser26) and primes it for inactivation.
Elimination of Ser26 phosphorylation promotes BAD
proapoptotic activity, thereby accelerating TNFa-
induced apoptosis in cultured cells and increasing
mortality in animals.Our results reveal that IKK inhibits
TNFa-induced apoptosis through two distinct but
cooperative mechanisms: activation of the survival
factor NF-kB and inactivation of the proapoptotic
BH3-only BAD protein.
INTRODUCTION
The IkB kinase complex (IKK) plays a central role in immune
responses, inflammation, cell survival, and tumorigenesis
(Baldwin, 2012; Ghosh and Karin, 2002; Karin and Ben-Neriah,
2000; Liu et al., 2012). IKK has two catalytic subunits, IKKa and
IKKb, and two regulatory subunits, NEMO/IKKg and ELKS
(Ghosh and Karin, 2002). IKK is activated by a variety of extra-
cellular stimuli, including inflammatory cytokines such as tumor
necrosis factor (TNFa) (Baldwin, 2012; Liu et al., 2012). Once
activated, IKK phosphorylates IkBs, which are a group of cyto-
plasmic inhibitors of NF-kB, on specific serines (Ser32 and304 Cell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc.Ser36 in IkBa and Ser19 and Ser21 in IkBb), triggering their
ubiquitination and subsequent degradation by the 26S protea-
some (Karin and Ben-Neriah, 2000). This frees NF-kB dimers to
translocate into the nucleus, where they stimulate transcription
of the target genes involved in immune responses, inflamma-
tion, viral infection, cell survival, and tumorigenesis (Baldwin,
2012; Ghosh and Karin, 2002; Karin and Ben-Neriah, 2000;
Liu et al., 2012). In addition to IkB proteins, IKK has several
other substrates, including A20, BCL-10, CYLD, FOXO3a,
histone H3, p85a, and RelA, which are involved in NF-kB acti-
vation or regulation of autophagy, allergy, immunity, and tumor-
igenesis (Anest et al., 2003; Comb et al., 2012; Hu et al., 2004;
Hutti et al., 2007; Sakurai et al., 1999; Reiley et al., 2005;
Wegener et al., 2006).
The prevailing paradigm of how IKK regulates TNFa-induced
apoptosis is the ‘‘NF-kB activation’’ model, in which the target
gene products of NF-kB inhibit caspases and prevent prolonged
JNK activation (Karin and Lin, 2002; Liu et al., 1996, 2004; Liu and
Lin, 2007; Tang et al., 2001, 2002; Wang et al., 1996a; Van
Antwerp et al., 1996). Genetic disruption of RelA alleles—which
are the major transactivating subunit of NF-kB in response to
TNFa—in mice results in embryonic lethality with massive
apoptosis of hepatocytes in the liver (Beg et al., 1995). The
embryonic lethality can be rescued by inactivation of TNF
receptor 1 (TNF-R1), demonstrating that RelA/NF-kB is neces-
sary for cell survival upon TNFa stimulation (Alcamo et al.,
2001). Genetic disruption of IKKb or NEMO/IKKg, but not IKKa,
in mice severely impairs NF-kB activation induced by TNFa
and other proinflammatory cytokines like IL-1, and like RelA/
NF-kB deficient mice, IKKb- or NEMO/IKKg-deficient mice also
have the embryonic lethality (Li et al., 1999a, 1999b; Rudolph
et al., 2000). Although activation of NF-kB by IKK is necessary
for inhibition of TNFa-induced apoptosis, it is not clear whether
IKK can inhibit TNFa-induced apoptosis independently of
NF-kB and, if so, what the molecular mechanism is.
The BH3-only protein BAD is a member of the proapoptotic
BCL-2 family and plays a critical role in regulation of the mito-
chondrial death machinery by extracellular stimuli (Danial and
Korsmeyer, 2004; Danial, 2008; Dragovich et al., 1998; Youle and
Strasser, 2008). In the presence of growth and survival factors,
BAD is phosphorylated at the ‘‘regulatory serines’’ (Ser112,
Ser136, and Ser155) in a sequential manner, in which phosphor-
ylation of Ser112 and Ser136 is required for phosphorylation of
Ser155 (Danial, 2008; Yaffe, 2002; Youle and Strasser, 2008).
Several protein kinases, including PKA, Raf-1, Akt/PKB, Rsk2,
and CaMKII, have been reported to phosphorylate BAD at one
or both of these regulatory serines in response to survival signals
(Bonni et al., 1999; Datta et al., 1997; del Peso et al., 1997;
Harada et al., 1999; Kelekar et al., 1997; Wang et al., 1996b;
Zha et al., 1996). In addition, JNK1 can phosphorylate BAD at
Thr201 in response to IL-3 and thereby inhibit the proapoptotic
activity of BAD (Yu et al., 2004). Upon withdrawal of survival
factors, BAD is hypophosphorylated and subsequently translo-
cates to mitochondrial membrane, where it binds to and inacti-
vates the antiapoptotic BCL-2 family protein BCL-XL (Danial
and Korsmeyer, 2004; Danial, 2008; Youle and Strasser, 2008).
However, the role of BAD in cell death induced by other death
stimuli like TNFa is poorly understood. Here, we report that
IKK inhibits TNFa-induced apoptosis through phosphorylation
and inactivation of BAD independently of NF-kB activation.
Thus, IKK inhibits TNFa-induced apoptosis through at least
two distinct mechanisms: activation of the survival factor
NF-kB and inhibition of the proapoptotic protein BAD.
RESULTS
IKK Is Able to Inhibit TNFa-Induced Apoptosis
Independently of NF-kB Activation
Wewerecuriouswhether IKKcan inhibit TNFa-inducedapoptosis
through an NF-kB-independent mechanism. Although RelA is the
major transactivating subunit of NF-kB in response tomany extra-
cellular stimuli, including TNFa, cRel has been reported to be able
to compensate NF-kBactivity in the absence of RelA (Barkett and
Gilmore, 1999; Gerondakis et al., 1999; Grossmann et al., 1999).
Thus, we used wild-type (WT), Ikkb/-, and RelA/-expressing
siRNA of cRel (RelA//sicRel) mouse embryonic fibroblasts
(MEFs). TNFa-induced expression of NF-kB target genes such
as IL-6 and IkBa was significantly reduced in RelA/ MEFs and
was further diminished in RelA//sicRel MEFs, as measured by
quantitative real-time PCR analysis (Figures S1A and S1B avail-
able online) or by luciferase assays using an NF-kB reporter
gene (Figure S1C). As expected, TNFa induced apoptosis in
both Ikkb/ and RelA//sicRel MEFs, but not in WT fibroblasts,
as measured by the cleavage of Casp-3 substrate PARP (Fig-
ure 1A). However, the rate of TNFa-induced apoptosis was signif-
icantly faster in Ikkb/ MEFs than that in RelA//sicRel MEFs;
the cleavage of PARP in Ikkb/ MEFs almost reached to the
maximum 5 hr after TNFa stimulation, compared to 9 hr in
RelA//sicRel MEFs (Figure 1A). Similar results were obtained
by Casp-3 activity assays (Figure 1B) and apoptotic cell death
assays (Figure 1C), although both kinds of cells died eventually.
However, this could be the result of the cell type difference. To
exclude this possibility, we used the approach of siRNA silencing.
Knockdown of IKKb by its specific siRNA in RelA//sicRel MEFs
significantly accelerated TNFa-induced apoptosis, as measured
by PARP cleavage (Figure 1D), Casp-3 activation (Figure 1E),and apoptotic cell death assays (Figure 1F). By contrast, knock-
down of RelA and cRel by their specific siRNAs in Ikkb/ MEFs
had no detectable effects on TNFa-induced apoptosis (Figures
1G–1I). Similar results were obtained when IKK was knocked
down in RelA/ MEFs and RelA was knocked down in Ikkb/
MEFs (Figures S1D–S1G). These data demonstrate that IKK can
inhibit TNFa-induced apoptosis through an NF-kB-independent
mechanism.
IKK, but Not NF-kB, Suppresses BAD Proapoptotic
Activity upon TNFa Stimulation
The above observation that Ikkb/ MEFs died significantly
faster than RelA//sicRel MEFs suggests that, in addition to
activation of NF-kB, IKK may inactivate a proapoptotic factor
or activate another survival factor. To test this hypothesis, we
determined whether IKK negatively regulates the BH3-only
protein BAD, which is a convergent point for many survival
signals (Danial and Korsmeyer, 2004; Danial, 2008; Dragovich
et al., 1998; Youle and Strasser, 2008). We found that silencing
of BAD by its specific siRNA significantly reduced TNFa-induced
apoptosis in Ikkb/MEFs, asmeasured by PARP cleavage (Fig-
ure 2A). Knockdown of BAD did not affect expression of BCL-XL,
which is a prosurvival BCL-2 family protein that antagonizes BAD
(Figure 2A). By contrast, knockdown of BAD had no detectable
effects on TNFa-induced apoptosis inRelA//sicRel MEFs (Fig-
ure 2B). Similar results were obtained by Casp-3 activity assays
(Figure 2C). Importantly, when BAD was knocked down, Ikkb/
andRelA//sicRel MEFs had similar apoptotic rates (Figure 2C).
These data indicate that the inability of inactivating BAD resulted
in the higher apoptotic death rate in Ikkb/MEFs (Figure 2A; see
also Figures 1A–1C). WhenWT and Bad/ fibroblasts were pre-
treated with the specific IKK inhibitor PS-1145 to block TNFa-
induced activation of IKK (Figure S2A), TNFa-induced apoptosis
was significantly reduced in Bad/MEFs compared with that in
WT fibroblasts (Figure 2D). Similar results were obtained with
primary hepatocytes, CHO, and FL83B cells (Figures S2C–
S2E). Thus, IKK suppresses TNFa-induced apoptosis through
inhibition of the proapoptotic BAD protein, in addition to activa-
tion of NF-kB in various mammalian cells.
To determine whether BAD is involved in TNFa-induced
apoptosis in vivo, we used WT and Bad knockout mice. When
D-GalN-sensitized mice were injected intraperitoneally with
TNFa, WTmice had severe liver damage with massive apoptosis
of hepatocytes (Figure 2E) and started to die around 6 hr (Fig-
ure 2F). By contrast, Bad/ mice were much less sensitive to
TNFa/D-GalN-induced apoptosis in liver, and the mortality was
significantly reduced (Figures 2E and 2F). These results demon-
strate that BAD is involved in TNFa-induced apoptosis in
animals.
IKK Is a BAD Kinase
Because IKK inhibits BAD proapoptotic activity upon TNFa stim-
ulation (Figure 2), we hypothesized that IKK may inhibit BAD
through phosphorylation. Immune complex kinase assays
showed that TNFa-activated IKK significantly phosphorylated
purified GST-BAD fusion proteins (Figure 3A). The ability of the
IKK complex to phosphorylate GST-BAD was well correlated
to its phosphorylation of GST-IkBa (Figure 3A), which is anCell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc. 305
Figure 1. IKK Is Able to Inhibit TNFa-Induced Apoptosis through NF-kB-Independent Mechanism
(A–C)WT, Ikkb/, andRelA/ fibroblasts were transfected with siRNA against cRel (sicRel) or control siRNA (siCtrl) as indicated for 24 hr, followed by stimulation
with or without TNFa (5 ng/ml). Cleavage of Casp-3 substrate PARP and expression of RelA, cRel, and IKKbwere analyzed by immunoblotting (A), measurement
of Casp-3 activity (B), and apoptotic cells, which were identified by Annexin V and PI staining followed by flow cytometric analysis (C).
(D–F) RelA/MEFs were transfected with sicRel, along with siIKKb or siCtrl for 24 hr, followed by stimulation with or without TNFa (5 ng/ml). PARP cleavage and
expression of IKKb and cRel were analyzed (D). Casp-3 activity (E) and apoptotic cell death (F) were measured as described in (B) and (C), respectively.
(G–I) Ikkb/ MEFs were transfected with siRelA plus sicRel or siCtrl for 24 hr, followed by stimulation with or without TNFa (5 ng/ml). PARP cleavage and
expression of RelA and cRel were analyzed (G). Casp-3 activity (H) and apoptotic cell death (I) were measured as in (B) and (C), respectively.
The results in (B), (C), (E), (F), (H), and (I) are presented as means ±SE and represent three individual experiments. *p < 0.05 and **p < 0.01, as analyzed by
Student’s t test. See also Figure S1.authentic IKK substrate. Knockout of IKKb, which is responsible
for suppressing TNFa-induced apoptosis (Ghosh and Karin,
2002), almost completely abolished phosphorylation of GST-
BAD by TNFa-activated IKK, whereas ectopic expression of
IKKb in Ikkb/MEFs restored the ability of IKK to phosphorylate
GST-BAD (Figure 3B). Thus, IKKb is not only required for activa-
tion of NF-kB but is also involved in phosphorylation of the pro-
apoptotic BAD protein upon TNFa stimulation.
Todeterminewhether IKKbcandirectlyphosphorylateBAD,we
used constitutively active IKKb(EE), in which Ser177 and Ser181
were replaced by glutamic acids (Mercurio et al., 1997; Zandi
et al., 1997). In vitro kinase assays showed that purified IKKb(EE)
significantly phosphorylated GST-BAD, as well as GST-IkBa, but
not JNK substrate GST-c-Jun (Figure 3C). Two-dimensional
tryptic phosphopeptide mapping revealed that GST-BAD phos-
phorylated by IKK isolated from nonstimulated fibroblasts (basal
IKK) contained two phosphopeptides, a and b (Figure 3D). When
GST-BAD phosphorylated by TNFa-activated IKK was analyzed,
the phosphopeptide a was significantly increased, whereas the
phosphopeptide b remained unchanged, with the appearance306 Cell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc.of another minor phosphopeptide c (Figure 3D). This suggests
that phosphopeptide a, as well as phosphopeptide c, to a much
less extent, were specifically phosphorylated by active IKK.
Similar results were obtained when IKKb(EE)-phosphorylated
GST-BADwas analyzed (Figure 3D). Phosphoamino acid analysis
revealed that GST-BAD phosphorylated by active IKK, as well as
the phosphopeptide a, only contained phosphoserine (PS) (Fig-
ure 3E). Taken together, these results demonstrate that IKKb is
a BAD kinase that phosphorylates BAD at serine residue(s).
IKK Is Necessary and Sufficient to Phosphorylate BAD at
Ser26 In Vitro and In Vivo
To identify IKK-phosphorylated serine residue(s), weconstructed
a C-terminal truncated GST-DC-BAD(1–114) and an N-terminal
truncated GST-DN-BAD(115–204) (Figure S3A). Immune com-
plex kinase assays showed that GST-DN-BAD(115–204) was
phosphorylated by basal IKK, and the phosphorylation was
only slightly increased when active IKK was used (Figure S3A).
By contrast, phosphorylation of GST-DC-BAD(1–114) was sig-
nificantly enhanced when TNFa-activated IKK was used
Figure 2. IKK, but Not NF-kB, Suppresses BAD Proapoptotic Activity upon TNFa Stimulation
(A–C) Ikkb/ or RelA/MEFs were transfected with siBad, sicRel, or siCtrl as indicated for 24 hr, followed by stimulation with or without TNFa (5 ng/ml). PARP
cleavage and expression levels of RelA, cRel, BAD, BCL-XL, and b-actin (A and B), as well as Casp-3 activity (C), were determined.
(D)WT andBad/MEFswere pretreatedwith orwithout the specific IKKb inhibitor PS-1145 (10 mM) for 2 hr, followed by stimulationwith orwithout TNFa (5 ng/ml).
Cleavage of pro-Casp-3 and PARP and expression levels of BAD, IkBa, and b-actin were determined. The data in (A)–(D) represent two to three individual
experiments with similar results.
(E and F) WT and Bad/mice were sensitized with D-GalN and then treated with TNFa (see Experimental Procedures for details). Dying animals were premoved,
and the liverswereextracted forH&Estaining andTunnel staining (E).Mortality ratewasdetermined, p<0.05; n=5 (F), as analyzedby the log rank (Mantel-Cox) test.
See also Figure S2.(Figure S3A). Two-dimensional phosphopeptide mapping anal-
ysis revealed that, in comparison to GST-BAD, GST-DN-BAD
contained phosphopeptide b, whereas GST-DC-BAD contained
phosphopeptide a (major) and c (minor) (Figure S3B). These
results indicate that active IKKphosphorylation site(s) are located
in the N-terminal half of BAD.
To determine the precise IKK-phosphorylation site(s) on BAD,
we systemically replaced all serine residues within the
N-terminal half (1–114) in the full-length GST-BADwith nonphos-
phorylatable alanines either individually or in different combina-
tions, using a site-directed mutagenesis approach (Figure S3C).
Immune complex kinase assays showed that TNFa-activated
IKK was unable to phosphorylate the GST-BAD(S26A) mutant
in comparison to WT GST-BAD (Figure 4A). Similar resultswere obtained with purified IKKb(EE) (Figure 4B). By contrast,
other GST-BAD mutants were still phosphorylated by active
IKK (Figure S3D). Two-dimensional phosphopeptide mapping
revealed that the replacement of Ser26 by Ala resulted in
complete elimination of the phosphopeptide a and c but had
no effects on phosphopeptide b (Figure 4C). Analysis of IKK-
phosphorylated GST-BAD proteins by tandem mass spectrom-
etry (MS/MS) also revealed that Ser26 was phosphorylated by
IKK (Figure 4D).
To analyze the regulation of BAD Ser26 phosphorylation
in vivo, we generated a rabbit polyclonal antibody using
a synthetic BAD phosphopeptide containing phosphorylated
Ser26 as an immunogen. Immunoblotting analysis revealed
that the anti-phospho-Ser26 antibody specifically recognizedCell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc. 307
Figure 3. IKK Is a BAD Kinase
(A) WT MEFs were stimulated with or without TNFa (5 ng/ml). IKK activity was determined by immune complex kinase assays with purified GST-IkBa (5 mg) or
GST-BAD (5 mg) as substrate. CBB, Coomassie brilliant blue staining.
(B) WT, Ikkb/, and Ikkb+ MEFs, in which Ikkb/MEFs were infected with adenoviral vector-encoding HA-IKKb (300MOI; 24 hr), were stimulated with or without
TNFa (5 ng/ml) for 10 min. IKK activity was determined as in (A).
(C) In vitro phosphorylation of purified GST-IkBa, GST-BAD, and GST-c-Jun (5 mg each) by constitutively active IKKb(EE) (24 ng), in which Ser177 and Ser181
were replaced by glutamic acids (EE) and has been purified to near homogeneity.
(D) Phosphorylated GST-BAD proteins were subjected to two-dimensional tryptic phosphopeptide mapping as described (Lin et al., 1992). Spot b is the major
tryptic peptide phosphorylated by basal IKK; spots a and c represent the peptides whose phosphorylation was augmented by active IKK or IKKb(EE).
(E) Phosphorylated BAD or the phosphopeptide a was subjected to phosphoamino acid analysis as described (Lin et al., 1992). PS, phosphoserine.
The data in (A)–(C) represent two to three individual experiments with similar results.active IKK-phosphorylated GST-BAD, but not nonphosphory-
lated GST-BAD or GST-BAD(S26A) mutant (Figure 4E). This
was not a result of the difference in the amount of GST-BAD
proteins, as analyzed by immunoblotting using anti-GST anti-
body (Figure 4E). Thus, anti-phospho-Ser26 antibody specifi-
cally recognizes BAD when it is phosphorylated at Ser26 by IKK.
To determine whether BAD is phosphorylated at Ser26 in
response to TNFa in an IKK-dependent manner, we used
Ikkb/ MEFs. Immunoblotting analysis using anti-phospho-
Ser26 antibody revealed that TNFa rapidly induced BAD phos-
phorylation at Ser26 in WT, but not in Ikkb/ MEFs (Figure 4F).
Consistently, ectopic expression of WT IKKb in Ikkb/ MEFs
restored BAD phosphorylation at Ser26 in response to TNFa
stimulation (Figure 4G). Furthermore, ectopic expression of the
constitutively active IKKb(EE) alone was sufficient to induce
BAD phosphorylation at Ser26 (Figure 4G). Interestingly, BAD
was also slightly phosphorylated at Ser26 in resting WT fibro-
blasts (Figure S3E, longer exposure). This basal level phosphor-
ylation of BAD at Ser26 was completely diminished in Ikkb/
MEFs (Figure S3E, longer exposure), suggesting that IKK is
also responsible for BAD basal Ser26 phosphorylation. Taken
together, IKK is necessary and sufficient for BAD phosphoryla-
tion at Ser26 under both basal and stimulated conditions.
IKK Inhibits the Association between BAD and BCL-XL
Independently of NF-kB Activation
Wehypothesized that phosphorylation by IKKmay promote BAD
interaction with 14-3-3, thereby preventing BAD from translocat-
ing to themitochondria to inactivate BCL-XL. To test this idea, we
examined the effect of IKKb on the subcellular localization of
BAD. TNFa induced apoptotic cell death in Ikkb/, but not in
WT fibroblasts, as previously reported (Tang et al., 2001; see308 Cell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc.also Figure 1). Immunoblotting analysis revealed that BAD and
Ser26-phosphorylated BAD exclusively localized in the cytosolic
fractions in TNFa-treatedWT fibroblasts (Figure 5A). By contrast,
a small portion (3%–6%) of the cytoplasmic BAD, which was
not phosphorylated at Ser26, translocated to the mitochondria
in TNFa-treated Ikkb/MEFs (Figure 5A). In fact, a small portion
of the cytoplasmic BAD started to translocate to mitochondria
as early as 5 min after TNFa stimulation in Ikkb/ MEFs
(Figure S4A). These results suggest that IKKb may inhibit mito-
chondrial translocation of BAD. However, it is possible that
translocation of BAD to the mitochondria is the consequence
of TNFa-induced apoptosis in Ikkb/ MEFs. To exclude this
possibility, we determined the effect of IKKb on the interaction
between BAD and 14-3-3 or BCL-XL. We found that BAD, as
well as Ser26-phosphorylated BAD, interacted with 14-3-3 in
the cytosol in TNFa-treated WT, but not in Ikkb/ fibroblasts
(Figure 5B). Although total cytosolic Ser26-phosphorylated
BAD was reduced with time, 14-3-3-associated Ser26-phos-
phorylated BAD remained unchanged even 3 hr after TNFa
stimulation, suggesting that binding with 14-3-3 may inhibit
dephosphorylation of Ser26-phosphorylated BAD. Conversely,
BCL-XL interacted with BAD in the mitochondrial fractions of
TNFa-treated Ikkb/, but not WT fibroblasts (Figure 5C). More
importantly, only nonphosphorylated, but not Ser26-phosphory-
lated, BAD was found to associate with BCL-XL at the mitochon-
dria (Figure 5C). Immunoprecipitation of BAD from themitochon-
dria fraction of TNFa-treated Ikkb/ MEFs also showed that
there was no Ser26-phosphorylated BAD (Figure S4B). Taken
together, these data demonstrate that phosphorylation of BAD
by IKK at Ser26 prevents BAD from translocating to the mito-
chondria to bind to and inactivate BCL-XL, thereby inhibiting
the proapoptotic activity of BAD upon TNFa stimulation.
Figure 4. IKK Is Necessary and Sufficient to Phosphorylate BAD at Ser26 In Vitro and In Vivo
(A and B) Phosphorylation of GST-BAD and GST-BAD(S26A) mutant proteins by active IKK (A) or purified IKKb(EE) proteins (B), as described in Figure 3B.
(C) Two-dimensional phosphopeptide mapping of active IKK-phosphorylated GST-BAD and GST-BAD(S26A) mutant proteins, as described in Figure 3D.
(D) GST-BAD proteins phosphorylated by active IKK in vitro were tryptic digested and then analyzed by mass spectrometry. Insert shows the recovered
phosphorylated peptide fragment corresponding to S26.
(E) GST-BAD and GST-BAD(S26A) proteins were phosphorylated by active IKK in the presence of nonradioactive ATP (17 mM) and analyzed by immunoblotting
using anti-phospho-Ser26 antibody.
(F) WT and Ikkb/MEFs were stimulated with or without TNFa (5 ng/ml). Ser26-phosphorylation of BAD and expression levels of BAD, IKKb, IkBa, and b-actin
were determined.
(G) Ikkb/MEFs were transfected with WT HA-IKK, constitutive active HA-IKKb(EE), or empty vector (1 mg each), followed by stimulation with or without TNFa
(5 ng/ml, 10 min). Ser26-phosphorylation of BAD and expression levels of HA-IKKb, HA-IKKb(EE), and IkBa were determined.
The data in (A), (B), and (E)–(G) represent two to three individual experiments with similar results. See also Figure S3.To determine whether inhibition of TNFa-induced BAD mito-
chondrial translocation by IKK is independent of NF-kB activa-
tion, we used RelA/ MEFs. We found that BAD, as well as
Ser26-phosphorylated BAD, associated with 14-3-3 in the cyto-
solic fractions in both TNFa-treated WT and RelA/ MEFs, but
not in Ikkb/ MEFs (Figure 5D). Consistently, BAD only associ-
ated with BCL-XL in the mitochondrial fractions of TNFa-treated
Ikkb/MEFs, but not WT and RelA/MEFs (Figure 5E). These
data demonstrate that inhibition of BAD by IKK is independent of
its activation of NF-kB.
IKK Primes BAD for Its Phosphorylation at the
Regulatory Serines
To understand how IKK inhibits BADmitochondria translocation,
we determined its effect on BAD phosphorylation at the regula-tory serines. Immunoblotting analysis revealed that phosphory-
lation of the regulatory serines (Ser112, Ser136, and Ser155)
was impaired in Ikkb/MEFs upon TNFa stimulation (Figure 6A).
This result suggests that IKK may prime BAD for its phosphory-
lation at the regulatory serines, thereby regulating BAD mito-
chondria translocation.
To determine whether inhibition of BAD mitochondria translo-
cation by IKK indeed depends on priming BAD phosphorylation
at the regulatory serines, Bad/ MEFs stably expressing
HA-BCL-XL were transiently transfected with M2-Bad WT
[Bad(WT)+] or M2-Bad(3SA) mutant, in which Ser112, Ser136,
and Ser155 were replaced by alanines [Bad(3SA)+] (Figure 6B).
Although BAD(3SA) mutant could not be phosphorylated at the
regulatory serines, it was still phosphorylated at Ser26 upon
TNFa stimulation (Figure 6B). Under the same conditions, a smallCell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc. 309
Figure 5. Phosphorylation of BAD by IKKb
Inhibits Its Proapoptotic Activity
(A) WT and Ikkb/ MEFs were treated with or
without TNFa (5 ng/ml) and then separated into
cytosol and mitochondrial fractions. Subcellular
localization of BAD, Ser26-phosphorylated BAD,
14-3-3, BCL-XL, and IKKb was analyzed by
immunoblotting. b-actin and COX-II were used as
cytosol and mitochondrial markers, respectively.
The amount of BAD in cytosol and mitochondrial
fractions in the same numbers of Ikkb/ MEFs
were quantitated by the Image J program.
(B and C) WT and Ikkb/ MEFs were treated with
or without TNFa (5 ng/ml) and fractionated as
described in (A). 14-3-3- and BCL-XL-associated
BAD or Ser26-phosphorylated BADwere analyzed
by immunoprecipitation in combination with
immunoblotting. BAD Ser26-phosphorylation,
expression levels of BAD, 14-3-3, BCL-XL, b-actin,
and COX-II were determined.
(D and E) WT, RelA/, and Ikkb/ MEFs were
stimulated with or without TNFa (5 ng/ml, 1 hr) and
then separated into cytosol (D) and mitochondria
(E) fractions. 14-3-3- and BCL-XL-associated BAD
or Ser26-phosphorylated BAD, BAD Ser26-phos-
phorylation, expression levels of BAD, 14-3-3,
BCL-XL, and COX-II were determined as des-
cribed in (B) and (C).
All data represent two to three individual experi-
ments with similar results. See also Figure S4.portion of BAD(3SA) mutant (3%–7%), but not WT BAD, trans-
located to the mitochondria (Figure 6C). Importantly, a similar
portion of Ser26-phosphorylated BAD(3SA) mutant (3%–6%)
also translocated to the mitochondria translocation (Figure 6C).
Furthermore, apoptotic cell death was significantly increased
in TNFa-treated Bad(3SA)+ MEFs in comparison with Bad(WT)+
MEFs (Figure 6D). Taken together, the inhibition of BAD mito-
chondria translocation and proapoptotic activity by IKK indeed
depends on priming BAD phosphorylation at the regulatory
serines.
To determine whether priming BAD phosphorylation at the
regulatory serines by IKK is involved in suppression of TNFa-
induced apoptosis in vivo, we used WT and Bad3SA/3SA knockin
mice. Immunoblotting analysis revealed that the expression level
of BAD(3SA) mutant was similar to that of endogenous BAD (Fig-
ure S5A). When D-GalN-sensitized mice were injected intraperi-
toneally with TNFa, Bad3SA/3SA knockin mice had accelerated
and severe liver damage with massive hepatocyte apoptosis
and mortality as compared to WT mice (Figures S5B and 6E).
These results suggest that priming BAD phosphorylation by
IKK at the regulatory serines is required for suppression of
TNFa-induced apoptosis in vivo.
Phosphorylation of BAD at Ser26 by IKK Inhibits the
Proapoptotic Activity of BAD
To determine the role of IKK-mediated Ser26 phosphorylation in
regulation of BAD proapoptotic activity, we established Bad/
stable cell lines expressing similar levels of WT M2-BAD or
M2-BAD(S26A) mutant (Figure S6A). As expected, immunoblot-310 Cell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc.ting analysis revealed that ectopically expressed WT BAD, but
not BAD(S26A) mutant, was phosphorylated at Ser26 upon
TNFa stimulation (Figure S6A). In addition, TNFa induced phos-
phorylation of WT BAD, but not BAD(S26A) mutant at Ser112,
Ser136, and Ser155 (Figure S6A). Furthermore, there were no
detectable differences in TNFa-induced activation of IKK and
NF-kB between Bad(WT)+ and Bad(S26A)+ MEFs, as measured
by IkBa degradation and resynthesis (Figure S6A) and by the
promoter activity of NF-kB by luciferase assays (Figure S6B).
These results demonstrate that elimination of IKK-mediated
Ser26-phosphorylation abrogates BAD phosphorylation at the
regulatory serines without affecting IKK activity and NF-kB acti-
vation upon TNFa stimulation.
Next, we determined whether IKK-mediated Ser26 phosphor-
ylation of BAD is required for suppression of TNFa-induced
apoptosis. TNFa induced apoptosis in both Bad(WT)+ and
Bad(S26A)+ MEFs when cells were infected with adenoviral
vector encoding HA-IkBa(AA) (Figure 7A). However, like Ikkb/
MEFs (Figure 1A) and Bad(3SA)+ MEFs (Figure 6D), Bad(S26A)+
MEFs were significantly more sensitive to TNFa-induced
apoptosis than Bad(WT)+ MEFs; PARP cleavage was detected
as early as 1 hr after TNFa stimulation in Bad(S26A)+ MEFs but
was detected 3 hr after in Bad(WT)+ MEFs (Figure 7A). Apoptotic
cell death assays also showed that Bad(S26A)+ MEFs died
significantly faster than Bad(WT)+ MEFs (Figure 7B). The differ-
ence in the apoptotic death rate between Bad(WT)+ and
Bad(S26A)+ MEFs mirrored the kinetic difference of TNFa-
induced apoptosis between RelA/ and Ikkb/ MEFs (Fig-
ure 1C). Similar results were obtained when Casp-3 activity
Figure 6. IKK Primes BAD Phosphorylation at the Regulatory Serines
(A) WT and Ikkb/ MEFs were treated with or without TNFa (5 ng/ml). Phosphorylation of BAD at various serines (Ser26, Ser112, Ser136, and Ser155) and
expression levels of BAD, IkBa, and b-actin were analyzed by immunoblotting.
(B–D) Bad/MEFs stably expressing HA-BCL-XL were transfected with WT M2-Bad [Bad(WT)
+] or M2-Bad(3SA) mutant, in which Ser112, Ser136, and Ser155
were replaced by analines [Bad(3SA)+] and then infected with adenoviral vector encoding HA-IkBa(AA), in which Ser32 and Ser36 were replaced by alanines, for
24 hr. Cells were treated with or without TNFa (5 ng/ml) and either directly harvested (B) or further separated into cytosol and mitochondria fractions (C).
Phosphorylation of Ser26 and the regulatory serines and expression levels of M2-BAD, HA-IkBa(AA), HA-BCL-XL, and b-actin were determined (B and C). At each
time point, the sum of cytoplasmic and mitochondrial Ser26-phosphorylated BAD(3SA) was calculated as 100% (C). The data in (A)–(C) represent two to three
individual experiments with similar results. Apoptotic cell death was determined (D). The results are presented as means ±SE and represent three individual
experiments. *p < 0.05 and **p < 0.01, as analyzed by Student’s t test.
(E) WT and Bad3SA/3SA knockin mice were sensitized by D-GalN and then injected intraperitoneally with TNFa, as described in Figures 2E and 2F. Dying animals
were premoved, and mortality rate was determined, p < 0.001; n = 6 (E), as analyzed by log rank (Mantel-Cox) test.
See also Figure S5.was measured (Figure 7C). Under the same conditions, TNFa
induced phosphorylation of the regulatory serine residues
(Ser112, Ser136, and Ser155) inBad(WT)+, but not inBad(S26A)+
MEFs (Figure 7D), suggesting that elimination of Ser26 phos-
phorylation promotes BAD proapoptotic activity.
To determine whether IKK-mediated Ser26-phosphorylation
of BAD is involved in TNFa-induced apoptosis in vivo, we used
WT and Bad knockout mice that have been reconstituted with
WT Bad or Bad(S26A) mutant via adenovirus infection. Immuno-
blotting analysis revealed that expression levels of reconstituted
BADwere similar to that of endogenous BAD (Figure S6C). When
D-GalN-sensitized mice were injected intraperitoneally with
TNFa, WT mice infected with Ad/Ctrl [WT+Ad/Ctrl] and Bad/
mice infected with Ad/WT Bad [Bad(WT)+] had similar levels of
liver damage and apoptosis of hepatocytes (Figure S6D), and
both died within 14 hr (Figure 7E), whereas Bad/mice infected
with Ad/Ctrl were much less sensitive to TNFa/D-GalN-induced
apoptosis in liver with significantly reduced mortality (Figure 7E),
which is consistent with the results in Figure 2F. By contrast,
Bad/ mice infected with Ad/Bad(S26A) mutant [Bad(S26A)+]had accelerated and severe liver damage with massive
apoptosis of hepatocytes (Figure S6D) and died within 10 hr
(Figure 7E). Taken together, these results demonstrate that
IKK-mediated Ser26-phosphorylation of BAD is required for
suppression of TNFa-induced apoptosis in vivo.
DISCUSSION
It has long been thought that IKK inhibits TNFa-induced
apoptosis through activation of NF-kB (Baldwin, 2012; Ghosh
and Karin, 2002; Karin and Ben-Neriah, 2000; Karin and Lin,
2002; Liu and Lin, 2007). Overwhelming evidence shows that
IKKb is essential for TNFa to activate NF-kB,which in turn inhibits
TNFa-induced apoptosis (Baldwin, 2012; Hoffmann and
Baltimore, 2006; Karin and Lin, 2002; Liu and Lin, 2007). Although
several IKK substrates, including p53, FOXO3a, TSC-1, IRS-1,
and Dok-1, are involved in cell survival related to allergy, immu-
nity, and cancer (Baldwin, 2012), their role in IKK-mediated inhi-
bition of TNFa-inducedapoptosis remains obscure. In this report,
we demonstrate that phosphorylation and inactivation of BAD byCell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc. 311
Figure 7. Elimination of Ser26-Phosphorylation Promotes the Proapoptotic Activity of BAD In Vitro and In Vivo
Bad/ MEFs stably expressing WT M2-Bad [Bad(WT)+] or M2-BAD(S26A) mutant [Bad(S26A)+] along with HA-BCL-XL were established as described in
Experimental Procedures.
(A–D) Bad(WT)+ and Bad(S26A)+ MEFs were infected with adenoviral vector encoding HA-IkBa(AA) for 24 hr and then treated with or without TNFa (5 ng/ml) as
indicated. PARP cleavage, expression of M2-BAD, HA-BCL-XL, HA-IkBa(AA), b-actin, and Ser26-phosphorylation of M2-BAD were analyzed (A). Apoptotic cell
death was analyzed by Annexin V/PI staining, followed by flow cytometric analysis (B), and Casp-3 activity was determined (C). The results in (B) and (C) are
presented as means ±SE and represent three individual experiments. *p < 0.05 and **p < 0.01, as analyzed by Student’s t test. Phosphorylation of M2-BAD at
various serine residues (Ser26, Ser112, Ser136, and Ser155) and expression levels of M2-BAD, HA-BCL-XL, HA-IkBa(AA), and b-actin were analyzed by
immunoblotting (D). The data in (A)–(D) represent two to three individual experiments with similar results.
(E) Bad/mice were injected intravenously with Ad/WT Bad, Ad/Bad(3SA) mutant, or Ad/Ctrl (see Experimental Procedures for details) and then challenged with
TNFa and D-GalN, as described in Figures 2E and 2F. Mortality rate was determined, p < 0.001; n = 10 (E), as analyzed by log rank (Mantel-Cox) test.
(F) A schematic presentation of the mechanism by which IKK inhibits TNFa-induced apoptosis through activation of NF-kB and inhibition of BAD.
See also Figure S6.IKK independently of NF-kB is required for suppressing TNFa-
induced apoptosis. Thus, IKK inhibits TNFa-induced apoptosis
through at least two distinct mechanisms: activation of NF-kB
and inhibition of BAD (Figure 7F).
Our finding that TNFa via IKK inhibits the proapoptotic activity
of BAD unmasks the involvement of a mitochondria-dependent
death pathway in TNFa-induced apoptosis. TNFa-induced
apoptosis is mainly mediated by the receptor-dependent death
pathway (Baud and Karin, 2001). Our results show that BAD
was involved in TNFa-induced apoptosis in various cultured cells
(fibroblasts, CHO, FL83B, and primary thymocytes and hepato-
cytes) (Figures 2D and S2C–S2E) and in animals (Figures 2E and
2F). Thus, TNFa can induce apoptosis through both receptor-
dependent death pathway and BAD-dependent mitochondrial
death pathway.
IKK is a BAD kinase upon TNFa stimulation. The proapoptotic
activity of BAD is inhibited by a variety of growth and survival
factors, which induce BAD phosphorylation at the regulatory
serines (Ser112, Ser136, and Ser155) and Thr201 (Danial and
Korsmeyer, 2004; Danial, 2008; Dragovich et al., 1998; Liu and
Lin, 2007; Youle and Strasser, 2008). Our results show that,
unlike known BAD kinases, IKK phosphorylated BAD at Ser26312 Cell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc.residue in vitro and in vivo (Figures 3 and 4). The phosphorylation
most likely occurred in the cytoplasm, as both Ser26-phosphor-
ylated BAD and IKKb exclusively resided in the cytoplasm in WT
fibroblasts (Figure 5A), and only non-Ser26-phosphorylated BAD
translocated to the mitochondria in Ikkb/ MEFs (Figure 5C).
Thus, like survival factors, the inflammatory cytokine TNFa also
inhibits BAD to suppress apoptosis.
Phosphorylation by IKK at Ser26 primes BAD for inactivation.
Previously, it has been reported that phosphorylation of Ser112
and Ser136 is required for phosphorylation of Ser155, although
the mechanism is still not known (Danial, 2008). Our results
show that phosphorylation of BAD by IKK at Ser26 prevented
BAD from translocating to the mitochondria (Figure 5A) by
promoting the interaction between BAD with 14-3-3 (Figure 5B)
and by suppressing the interaction between BAD with BCL-XL
(Figure 5C). Because the surrounding amino acids of Ser26
(DPGIRpSLG) do not comprise the 14-3-3 bindingmotif (typically
RSXpS/TXP or RXXXXpS/TXP; Yaffe, 2002), IKK is most likely to
regulate the association of BADwith 14-3-3 indirectly. In support
of this notion, our data show that phosphorylation of BAD at the
regulatory serines was impaired in Ikkb/MEFs (Figure 6A) and
Bad/MEFs expressing BAD(S26A) mutant (Figure S6A). Thus,
phosphorylation of BAD by IKK at Ser26 is a prerequisition for
BAD to be further phosphorylated at the regulatory serines.
The Ser26-phosphorylated BAD(3SA) mutant still translocated
to the mitochondria to induce apoptosis in TNFa-treated
Bad(3SA)+ MEFs (Figures 6B–6D), suggesting that Ser26-phos-
phorylation indeed depends on phosphorylation of the regula-
tory serines to exert its function. The percentage of Ser26-
phosphorylated BAD(3SA) mutant is similar to that of BAD(3SA)
mutant (Figure 6C) or BAD (Figure 5A) that translocates to
the mitochondria in the early time period after TNFa stimulation
(%2 hr), indicating that phosphorylation of BAD by IKK at
Ser26 plays a critical role in inhibiting the initiation of BAD mito-
chondrial translocation, thereby suppressing its proapoptotic
activity. Future structural studies are needed to determine the
mechanism underlying the priming effect of IKK-mediated
Ser26 phosphorylation.
The inhibition of BAD by IKK is independent of NF-kB. Over-
whelming evidence shows that IKK inhibits TNFa-induced
apoptosis through activation of NF-kB (Baldwin, 2012; Ghosh
and Karin, 2002; Karin and Ben-Neriah, 2000; Karin and Lin,
2002; Liu and Lin, 2007). Our results show that IKK directly phos-
phorylated BAD at Ser26, thereby inhibiting its proapoptotic
activity upon TNFa stimulation (Figures 3, 4, 5, 6, and 7). This
inhibition is independent of NF-kB, as BAD was still phosphory-
lated at Ser26 by IKK and was sequestered in the cytosol of
RelA/ MEFs (Figures 5D and 5E). Conversely, elimination of
IKK-mediated BAD phosphorylation had no significant effects
on RelA activation (Figures S6A and S6B). Although we cannot
formally exclude that other IKK substratesmight also be involved
in regulation of TNFa-induced apoptosis, inactivation of BAD is
an NF-kB-independent axis of the IKK survival signaling in
suppression of TNFa-induced apoptosis.
The inactivation of BAD by IKK via Ser26 phosphorylation has
physiological significance. Our results show that Ikkb/ MEFs
died significantly faster than RelA//sicRel MEFs (Figures 1A–
1C). This was due to lack of inhibition of BAD by IKK in Ikkb/
MEFs, as knockdown of BAD in Ikkb/MEFs almost completely
eliminated the difference (Figure 2C). Consistently, Bad(S26A)+
MEFs died significantly faster than Bad(WT)+ MEFs (Figures
7A–7C). More importantly, Bad(S26A)+ mice had much earlier
onset of liver damage with massive apoptosis of hepatocytes
(Figure S6D) and died significantly faster than Bad(WT)+ mice
(Figure 7E). Thus, phosphorylation of BAD at Ser26 by IKK is
a physiologically relevant and important regulation. This conclu-
sion is further supported by the observations that similar results
were obtained in Bad3SA/3SA knockin mice (Figures 6D, 6E, and
S5B). Our findings are also consistent with previous reports
that Ikkb/ mice died earlier (E13.5) (Li et al., 1999a, 1999b)
than RelA/ mice (E15–E16) (Beg et al., 1995). The inability of
inactivating BAD in Ikkb/ mice might account for their earlier
embryonic lethality. Future studies are needed to explore this
scenario.
Inactivation of BAD by IKK may work in coordination with acti-
vation of NF-kB to inhibit TNFa-induced apoptosis. As a key
survival factor, NF-kB is essential for cell survival upon TNFa
stimulation. However, NF-kB activation is a relatively slow
process that involves IkBa phosphorylation, ubiquitination, and
degradation; nuclear translocation of NF-kB dimmer; inductionof NF-kB target genes; and synthesis of corresponding protein
products (Ghosh and Karin, 2002; Karin and Ben-Neriah,
2000). By contrast, inactivation of BAD by IKK is direct and rapid.
Our results show that BAD was phosphorylated by IKK at Ser26
within minutes in TNFa-stimulated WT fibroblasts (Figures 4F,
6A, and S4). In the absence of IKKb, BAD started to translocate
to the mitochondria as early as 5 min after TNFa stimulation (Fig-
ure S4). It is most likely that BAD may be involved in the initiation
of TNFa-induced apoptosis. The rapid inactivation of BADby IKK
may be critical to protect cells from TNFa-induced apoptosis
before IKK-activated NF-kB is able to induce inhibitors of
apoptosis (IAPs) to suppress the apoptosis. Thus, the two
parallel and independent signaling axes of IKK (i.e., activation
of NF-kB and inhibition of BAD) may function in coordination in
inhibition of TNFa-induced apoptosis (Figure 7F).EXPERIMENTAL PROCEDURES
Reagents
Antibodies against BAD, IkBa, PARP, phospho-IKKa/b, phospho-BAD(S112),
phospho-BAD (S136), and phospho-BAD(S155) were fromCell Signaling. Anti-
phospho-BAD(S26) antibody was custom made by Abiocode Inc. using the
synthetic phosphopeptide RKSDPGIRpSLGSD as the immunogen. Antibodies
against COX-II, BCL-XL, IKKg, RelA, cRel, pan 14-3-3, and Casp-3 were from
Santa Cruz. Antibody against IKKb was from Millipore. Anti-M2 antibody, the
IKKb inhibitor PS-1145, and Hoechst were from Sigma. Propidium iodide (PI)
and Annexin V were from BD PharMingen. D-Galactosamine Hydrochloride
(D-GalN) was from MP Biomedicals. [32P]ATP was from PerkinElmer. TNFa
was from R&D (murine) or PeproTech (human). pcDNA3.1-Hygromycin(+)
vectors encoding M2-BAD or M2-BAD(S26A) mutant were subcloned, as
described previously (Yu et al., 2004). S26A mutation and 3SA mutation
were introduced using Quick-Change site-directed mutagenesis kit (Strata-
gene) and were verified by DNA sequencing. Expression vectors encoding
HA-BCL-XL, GST-BAD, GST-c-Jun, GST-IkBa, GST-DN-BAD(115–204), and
GST-DC-BAD(1–114) were described previously (Yu et al., 2004). HA-IKKb,
HA-IKKb(EE), and NF-kB luciferase reporter gene were gifts from Dr. Joseph
A. DiDonato at Cleveland Clinic Foundation. IKKb(EE) protein, which had
been purified to near homogeneity from baculovirus-encoding IKKb(EE)-
infected sf9 cells, was a gift fromDr. FrankMuricio at Cellgene. The sequences
of siRNA are siBAD: AGCUCCUGUUUGGAGUUUCAAA, siIKKb: CAGAA
GAGCGAAGUGG ACAUCU, siRelA: GAGUUUCAGCAGCUCCUGAAC, and
siCtrl: GGAGCGCACCAUCUUCUUC. The recombinant adenovirus encoding
WT Bad, Bad(S26A), or Bad(3SA) mutant or the EGFP control were generated
using standard procedures and were purified by CsCl density gradient centri-
fugation (Xiang et al., 2000).Cell Culture and Transfection
WT, Ikkb/, and RelA/ MEFs and CHO cells were gifts from Dr. Michael
Karin at University of California, San Diego. Bad/ MEFs were described
previously (Ranger et al., 2003). FL83B cells were from ATCC. Cells were
grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum, 2 mM glutamine, 100 U/ml penicillin, and 100 mg/ml strepto-
mycin. To establish Bad/ MEFs stably expressing WT BAD or BAD(S26A)
mutant, Bad/ MEFs were first transfected with pcDNA3.1-Puromycin(+)-
HA-BCL-XL and selected with puromycin (1.5 mg/ml). Bad
/ MEFs stably
expressing HA-BCL-XL were then transfected with pcDNA3.1-Hygromy-
cin(+)-M2-BAD or -M2-BAD(S26A) and were further selected with hygromycin
(100 mg/ml).Animal Experiments
Bad/ and Bad3SA/3SAmice were described previously (Danial, 2008). Bad/
mice were injected through tail vein with recombinant adenoviral vector
encodingBad(WT) orBad(S26A)mutant (a total dose of 43 109 infectious unitsCell 152, 304–315, January 17, 2013 ª2013 Elsevier Inc. 313
per ml [IFUs] in a volume of 100 ml per animal) to generate Bad(WT)+ and
Bad(S26A)+ mice, respectively.
To determine the role of IKK-mediated phosphorylation and inactivation of
BAD in TNFa-apoptosis in vivo, WT, Bad/, Bad3SA/3SA knockin, and various
reconstituted Bad/ mice (6–8 weeks old, 20–24 g) were sensitized by i.p.
administration of 700 mg/kg body weight of D-GalN and then treated with
i.p. administration of 15 mg/kg body weight of hTNFa. All reagents were
balanced with sterile PBS so that the total volume of injecting solution in
different mice was the same. Mortality rate was recorded every 2 hr for up to
25 hr after the treatment. The animal protocols were approved by University
of Chicago Institutional Animal Care and Use Committee. To analyze liver
injury, livers were isolated from premoved mice, and the liver lobes were
excised and fixed in 4% paraformaldehyde for 12 hr. The tissues were sliced
to 5 mm thickness. H&E staining was performed at the University of Chicago
Human Tissue Resource Center (HTRC). In situ cell death was analyzed by
TUNEL staining (TUNEL Apoptosis Detection kit, EMD Millipore) according
to the manufacturer’s protocol.
Statistical Analysis
The percentage of apoptotic cells among groups was determined using
Student’s t test. Mouse survival curves were constructed using the Kaplan-
Meier product limit estimator and compared using the log rank (Mantel-Cox)
test. p < 0.05 was considered to be significant in all experiments.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six figures and can be found with this article online at http://dx.doi.org/10.
1016/j.cell.2012.12.021.
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